Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-24-076294
Filing Date
2024-06-28
Accepted
2024-06-28 16:19:32
Documents
24

Document Format Files

Seq Description Document Type Size
1 S-1/A tm2319041-16_s1a.htm S-1/A 2174804
2 EXHIBIT 1.1 tm2319041d16_ex1-1.htm EX-1.1 337332
3 EXHIBIT 3.1 tm2319041d19_ex3-1.htm EX-3.1 51130
4 EXHIBIT 4.2 tm2319041d19_ex4-2.htm EX-4.2 93620
5 EXHIBIT 5.1 tm2319041d19_ex5-1.htm EX-5.1 13798
6 EXHIBIT 23.1 tm2319041d19_ex23-1.htm EX-23.1 2604
7 EX-FILING FEES tm2319041d19_ex-filingfees.htm EX-FILING FEES 9945
8 GRAPHIC lg_lirum-4clr.jpg GRAPHIC 10061
9 GRAPHIC fc_precision-4c.jpg GRAPHIC 73179
10 GRAPHIC fc_program-4c.jpg GRAPHIC 39001
11 GRAPHIC tb_igf-4c.jpg GRAPHIC 74211
12 GRAPHIC tb_approach-4c.jpg GRAPHIC 70114
13 GRAPHIC tb_uniquely-4c.jpg GRAPHIC 70396
14 GRAPHIC lc_efficacy-4clr.jpg GRAPHIC 114230
15 GRAPHIC tb_dose-4c.jpg GRAPHIC 69719
16 GRAPHIC tb_tumortype-4c.jpg GRAPHIC 88405
17 GRAPHIC tb_cancer-4c.jpg GRAPHIC 97580
18 GRAPHIC tb_preclinical-4clr.jpg GRAPHIC 90522
19 GRAPHIC lc_ewing-4clr.jpg GRAPHIC 69378
20 GRAPHIC fc_condition-4clr.jpg GRAPHIC 93578
21 GRAPHIC fc_aberrant-4c.jpg GRAPHIC 98263
22 GRAPHIC tb_historical-4c.jpg GRAPHIC 71308
23 GRAPHIC tb_lirumapproach-4c.jpg GRAPHIC 84621
24 GRAPHIC tm2319041d19_ex5-1img001.jpg GRAPHIC 8142
  Complete submission text file 0001104659-24-076294.txt   4368628
Mailing Address 590 MADISON AVENUE SUITE 21ST FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE SUITE 21ST FLOOR NEW YORK NY 10022 917-376-2350
Lirum Therapeutics, Inc. (Filer) CIK: 0001965411 (see all company filings)

EIN.: 881228824 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-277822 | Film No.: 241086016
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)